334 related articles for article (PubMed ID: 36768288)
1. The Roles of Exosomes in the Diagnose, Development and Therapeutic Resistance of Oral Squamous Cell Carcinoma.
Shi S; Yu ZL; Jia J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768288
[TBL] [Abstract][Full Text] [Related]
2. Emerging functions and applications of exosomes in oral squamous cell carcinoma.
Qie Y; Sun X; Yang Y; Yan T
J Oral Pathol Med; 2023 Nov; 52(10):886-894. PubMed ID: 37701945
[TBL] [Abstract][Full Text] [Related]
3. Exosomes: A Cutting-Edge Theranostics Tool for Oral Cancer.
Kalele K; Nyahatkar S; Mirgh D; Muthuswamy R; Adhikari MD; Anand K
ACS Appl Bio Mater; 2024 Mar; 7(3):1400-1415. PubMed ID: 38394624
[TBL] [Abstract][Full Text] [Related]
4. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma.
Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J
Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982
[TBL] [Abstract][Full Text] [Related]
5. miR-365 (microRNA): Potential Biomarker in Oral Squamous Cell Carcinoma Exosomes and Extracellular Vesicles.
Coon J; Kingsley K; Howard KM
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32727045
[TBL] [Abstract][Full Text] [Related]
6. MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral Cancer.
Sayyed AA; Gondaliya P; Mali M; Pawar A; Bhat P; Khairnar A; Arya N; Kalia K
Mol Pharm; 2021 Aug; 18(8):3010-3025. PubMed ID: 34176265
[TBL] [Abstract][Full Text] [Related]
7. Salivary Exosomal miRNA-1307-5p Predicts Disease Aggressiveness and Poor Prognosis in Oral Squamous Cell Carcinoma Patients.
Patel A; Patel S; Patel P; Mandlik D; Patel K; Tanavde V
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142544
[No Abstract] [Full Text] [Related]
8. Current Status, Opportunities, and Challenges of Exosomes in Oral Cancer Diagnosis and Treatment.
Liu H; Huang Y; Huang M; Huang Z; Wang Q; Qing L; Li L; Xu S; Jia B
Int J Nanomedicine; 2022; 17():2679-2705. PubMed ID: 35733418
[TBL] [Abstract][Full Text] [Related]
9. Engineered exoASO-STAT6: a potent monotherapy for oral squamous cell carcinoma.
Jayaseelan VP; Paramasivam A
Future Oncol; 2022 Aug; 18(25):2767-2769. PubMed ID: 35766123
[No Abstract] [Full Text] [Related]
10. Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes.
Sento S; Sasabe E; Yamamoto T
PLoS One; 2016; 11(2):e0148454. PubMed ID: 26849680
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma through macropinocytosis.
Sasabe E; Tomomura A; Liu H; Sento S; Kitamura N; Yamamoto T
Cancer Sci; 2022 Feb; 113(2):609-621. PubMed ID: 34874595
[TBL] [Abstract][Full Text] [Related]
12. Exosomes at the crossroad between therapeutic targets and therapy resistance in head and neck squamous cell carcinoma.
Jangholi A; Müller Bark J; Kenny L; Vasani S; Rao S; Dolcetti R; Punyadeera C
Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188784. PubMed ID: 36028150
[TBL] [Abstract][Full Text] [Related]
13. Exosomes in head and neck cancer. Updating and revisiting.
Rodríguez Zorrilla S; García García A; Blanco Carrión A; Gándara Vila P; Somoza Martín M; Gallas Torreira M; Pérez Sayans M
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1641-1651. PubMed ID: 31496355
[TBL] [Abstract][Full Text] [Related]
14. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
[TBL] [Abstract][Full Text] [Related]
15. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
16. Tumor-derived exosomes elicit cancer-associated fibroblasts shaping inflammatory tumor microenvironment in head and neck squamous cell carcinoma.
Mito I; Takahashi H; Kawabata-Iwakawa R; Horikawa M; Ida S; Tada H; Matsuyama T; Misawa K; Takeda S; Chikamatsu K
Oral Oncol; 2023 Jan; 136():106270. PubMed ID: 36462328
[TBL] [Abstract][Full Text] [Related]
17. Radiation alters the cargo of exosomes released from squamous head and neck cancer cells to promote migration of recipient cells.
Mutschelknaus L; Azimzadeh O; Heider T; Winkler K; Vetter M; Kell R; Tapio S; Merl-Pham J; Huber SM; Edalat L; Radulović V; Anastasov N; Atkinson MJ; Moertl S
Sci Rep; 2017 Sep; 7(1):12423. PubMed ID: 28963552
[TBL] [Abstract][Full Text] [Related]
18. Macrophage‑derived exosomes attenuate the susceptibility of oral squamous cell carcinoma cells to chemotherapeutic drugs through the AKT/GSK‑3β pathway.
Tomita R; Sasabe E; Tomomura A; Yamamoto T
Oncol Rep; 2020 Nov; 44(5):1905-1916. PubMed ID: 32901850
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p.
Li YY; Tao YW; Gao S; Li P; Zheng JM; Zhang SE; Liang J; Zhang Y
EBioMedicine; 2018 Oct; 36():209-220. PubMed ID: 30243489
[TBL] [Abstract][Full Text] [Related]
20. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
